Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2.

B D Curti; D L Longo; A C Ochoa; K C Conlon; J W Smith; W G Alvord; S P Creekmore; R G Fenton; B L Gause; J Holmlund

doi:10.1200/JCO.1993.11.4.652

Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2.

Identifier:nobleid.org/w1/20260515/4C5E7CD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4C5E7CD3.svg?ark=w1%2F20260515%2F4C5E7CD3)](https://nobleid.org/work/w1/20260515/4C5E7CD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2.

Identifier:nobleid.org/w1/20260515/4C5E7CD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4C5E7CD3.svg?ark=w1%2F20260515%2F4C5E7CD3)](https://nobleid.org/work/w1/20260515/4C5E7CD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work